Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
CompletedOBSERVATIONAL
Enrollment
65
Participants
Timeline
Start Date
February 27, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
October 27, 2021
Conditions
Sickle Cell Disease (SCD)
Trial Locations (1)
20892
National Heart, Lung and Blood Institute (NHLBI), Bethesda
All Listed Sponsors
lead
National Heart, Lung, and Blood Institute (NHLBI)
NIH
NCT03478917 - Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging | Biotech Hunter | Biotech Hunter